Diabetes

>

Latest News

Image Credit: © Calin - stock.adobe.com
FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up

December 23rd 2024

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial | Image Credit: © Africa Studio - © Africa Studio - stock.adobe.com.
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial

December 20th 2024

Resilience programs improve behavioral outcomes in adolescents with T1D distress | Image Credit: © Alina - © Alina - stock.adobe.com.
Resilience programs improve behavioral outcomes in adolescents with T1D distress

October 16th 2024

 Image Credit: © Artur - ©Artur - stock.adobe.com.
Weekly review: Extended labels, T1D inheritance data, and more

August 2nd 2024

Phase 3 type 1 diabetes precision medicine trial receives positive interim analysis | Image Credit: © Michael O'Neill - © Michael O'Neill - stock.adobe.com.
Diamyd phase 3 type 1 diabetes precision medicine trial receives positive interim analysis

August 1st 2024

© 2024 MJH Life Sciences

All rights reserved.